Diverse roles of STING-dependent signaling on the development of cancer

Area of Science:

• Immunology
• Oncology
• Cellular Biology

Background:

• Stimulator of interferon genes (STING) is a key sensor in innate immunity, regulating cytosolic DNA-activated signaling.
• STING-deficient mice are resistant to skin cancer, unlike MyD88-deficient mice, due to prevented pro-tumorigenic cytokine production.
• MyD88-deficient mice are susceptible to colitis-associated cancer (CAC), as some DNA-damage-induced cytokines promote repair and prevent tumors.

Purpose of the Study:

• To investigate the role of STING signaling in wound repair and its impact on colitis-associated cancer (CAC).
• To compare the susceptibility of STING-deficient mice to CAC with that of MyD88-deficient mice.
• To identify specific molecular mechanisms, such as cytokine involvement, underlying STING's role in intestinal tumorigenesis.

Main Methods:

• Utilized STING-deficient (SKO) mice and MyD88-deficient mice models.
• Induced colitis-associated cancer using DNA-damaging agents.
• Assessed STING signaling's role in wound repair processes.
• Quantified levels of key cytokines, including interleukin-22 binding protein (IL-22BP), in tumor-bearing mice.

Main Results:

• STING signaling was found to facilitate wound repair processes.
• STING-deficient mice exhibited increased susceptibility to CAC, similar to MyD88-deficient mice.
• Tumors in STING-deficient mice showed significantly lower levels of the tumor-suppressive cytokine IL-22BP compared to controls.

Conclusions:

• STING signaling is a critical component of the early host response to intestinal damage.
• STING is essential for activating tissue repair pathways that help prevent colon tumorigenesis.
• Dysregulation of STING-mediated repair pathways may contribute to the development of colitis-associated cancer.